Health Economic
Research and
Quality of Life Evaluation Services
Helping
pharmaceutical, biotechnology and medical device companies quantify and
communicate the value of their products in a competitive global
marketplace
Economic Modeling and Retrospective
Analysis
Quality of Life / Patient-Reported
Outcomes Assessment and Tool Development
Strategy Design, Pricing Support and
Complementary Services
Managed Care Dossier Preparation
Manuscript Preparation for
Peer-Reviewed Publications and Support for other Professional
Communication Activities
Patient Registries and Other
Prospective Studies
For more information, please contact:
Chris L. Pashos, Ph.D. Tel: 1 617 520 2935
E-mail:
chris_pashos@abtassoc.com
The Analytica Group is a research consultancy that provides
timely delivery of market-driven Health Economics and Outcomes Research.
Based in Manhattan, the group is currently conducting research in the
United States, Canada, Europe, Latin America, and Asia. The multi-national
and multi-disciplinary staff includes physicians, epidemiologists,
economists, engineers, pharmaceutical research scientists, and
biostatisticians. The Analytica Group is currently engaged with eight of
the top ten pharmaceutical companies in the world.
450 Park Avenue South
New York, NY 10016
T: 212-686-4100
F: 212-686-8601 www.groupanalytica.com
Assist Technologies is the leading
innovator of software and services for patient-reported outcomes surveys.
Replacing traditional paper and pencil methods, Assist offers
Windows-based software allowing patients to respond to surveys via
touch-screen technology. Assist also offers a complete turnkey solution
including: research/site team training, electronic uploads, data
consolidation, and quality assurance.
Established in 1987, The EuroQol Group
consists of a network of international multi-disciplinary researchers
from Europe, North America, New Zealand, South Africa and Japan. Their
collaboration resulted in EQ-5D - a standardised, non-disease-specific
instrument for describing and valuing health. EQ-5D is in widespread
use in many countries and has been applied in many different settings.
EQ-5D is now an integral feature of many clinical trials and is
increasingly used in population health surveys. EQ-5D is also being
used by eight out of the first ten of the top fifty pharmaceutical
companies listed in the annual report of Pharma Business
(November/December 1999). Furthermore, EQ-5D is one of a handful of
measures recommended for use in cost-effectiveness analyses by the
Washington Panel on Cost Effectiveness in Health & Medicine.
The EuroQol Group Foundation is formally registered in the
Netherlands. The objective of the Foundation is to promote the
scientific interests of the EuroQol Group. The Foundation has a formal
Board of Management and a growing Business Management Office in the
Netherlands which is a focal point for communication and provides
services for distribution, co-ordination and quality control. The
EuroQol Business Management maintains a website at
www.euroqol.org. For more
information, contact the EuroQol Business Manager, dr. Frank de Charro
at fdecharro@compuserve.com.
Health Core is an outcomes and
clinical research organization working with both suppliers
and purchasers of health care services, specifically in the
prospective and retrospective research managed care setting.
Health Core’s integrated research database includes over 35 Million
pharmacy lives, 18 million medical lives, 8 million Quality Data
Lives (“researchable”), and almost 1 million integrated lab result
information. Our database also captures true patient enrollment,
benefit design, formulary status, co-pay, and charge/paid
information.
Whether it is managed care strategies, market assessments, MCO/PBM/Physician/Patient/Employer
surveys, clinical trials, outcomes research, chart-level research,
prospective effectiveness studies, or predictive modeling/budget
impact tools, Health Core is positioned to provide “real-world”
evaluation for both purchasers and suppliers of health care products
and services.
For more information, please contact: ISPOR Booth # 27
Gordon Cummins, MS
Vice President
Tel: 302-623-0536
Email:
GCummins@HealthCore.com
Phone: 905-525-9140
Ext: 22389 and 22377
FAX: 905-627-7914
HEED: the Health Economic Evaluations Database
The problem is the number of economic studies in many fragmented sources.
The solution is HEED
HEED is the world’s
leading database of economic evaluation in health care comprising
26,500 evaluations in an easy to read structured format with a 60
field search capability that includes free text and Expert
searching. It’s an International database containing non-English
language evaluations and covers evaluations from 1967 to current
date
HEED database covers
several types of economic evaluation including Cost effectiveness
analysis, Cost consequence analysis, Cost minimization analysis,
Cost benefit analysis and Cost utility analysis. For completeness,
studies on Cost of illness and Cost analysis are also included.
HEED is updated on a
monthly basis, is available as an annual subscription service on
either CD-ROM or via the Internet
Operating in
more than 100 countries, IMS HEALTH
is the world's leading provider of information solutions to the
pharmaceutical and healthcare industries. With $1.4 billion in 2002
revenue and nearly 50 years of industry experience, IMS offers
leading-edge business intelligence products and services that are integral
to clients’ day-to-day operations, including marketing effectiveness
solutions for prescription and over-the-counter pharmaceutical products;
sales optimization solutions to increase pharmaceutical sales force
productivity; and consulting and customized services that turn information into actionable insights.
Institute of Empirical Health Economics
Am Ziegelfeld 28; D - 51399 Burscheid
phone: +49-(0)2174 / 7151-0
fax: +49-(0)2174/ 7151-98
e-mail: info@ifeg.de
Internet: www.ifeg.de
The Institute of
Empirical Health Economics provides analytical services to health
care authorities, international pharmaceutical companies, sickness
funds and health care insurers and clinical research programmes.
Our services are:
Consulting
Outcomes research
Disease and case
management / evaluation
Pharmacoeconomics
Reimbursement
procedures for drugs diagnostics and medical devices
Standard
operating procedures (SOPs) and Benchmarking
Moderation and
joint meetings with health care providers and payers
The JeSTARx Group, is focused on the
needs of healthcare companies by:
Developing health economics,
medical communication, and training programs,
Recruiting for, managing, and
conducting advisory boards,
Designing, implementing, and
monitoring study protocols,
Assisting sales and marketing in
strategy and execution,
Conducting market research,
Developing models that define
improved care,
Editorial support
Our CRO capabilities have been
utilized by several large pharmaceutical organizations. As part of the
qualification process they have investigated our protocols and
procedures and subsequently retained our organization. Using OCR/OMR
and IVR technologies, we have conducted a variety of studies in
timeframes considered impossible by in-house infrastructures, at a
fraction of the cost of using typical CROs. Our Credo is of maximum
data capture with minimum effort on the part of the investigational
team.
Building the Science of Quality of Life
Mapi Research Institute
is an international non-profit health outcomes organisation established
to support and promote collaborative research in the field of
patient-reported outcomes (PRO) since 1994. Our non-profit philosophy
means we constantly reinvest in the field through the development of
important initiatives and in providing the most comprehensive library and
expert network available in the field of PRO. The Institute’s team of
experienced professionals offers a wide range of expertise and research
services including:
PRO information searches
Extensive literature
reviews in PRO
Publication twice a year
of the Quality of Life Newsletter since 1991
Development of
“QOLID”,
the Quality of Life Instruments Database (www.qolid.org)
Translation and
linguistic validation of PRO measures
Development and
presentation of practical and interactive PRO educational programmes
(Workmats)
Creation and coordination
of research projects:
European Regulatory Issues on
Quality of Life Assessment (ERIQA) projec
A leader in providing research and
normative databases to support drug discovery and post-launch analytics.
Medstat’s products and services focus on:
• Market assessment
• Economic and clinical evaluation of the marketplace
• Clinical trial design
• Clinical trial recruitment
• Decision analytic modeling and interactive tools
• Market share monitoring
Medstat’s well-published researchers are supported by the MarketScan®
Research Databases, the analytical and normative gold standard for the
pharmaceutical industry.
MetaWorks®
Inc.
Harnessing the Power of
Data for Healthcare
The Pharmaceutical
Industry’s
premier source of literature derived
evidence-based research studies:
•Outcomes Research
• Pharmacoeconomic
• Pharmacovigilance
• Humanistic
If you’re considering systematic-review
and meta-analysis to harness the vast
medical literature, then MetaWorks should
be your first stop. Visit us at the ISPOR
Exhibition, booth #49, or on the web
at
www.metaworksinc.com.
Outcome Technologies
is a dedicated outcome services provider supplying software,
services, and data for outcomes research and health economics.
Formed by doctors to meet the increasing needs of managing outcome
data in the clinical environment, Outcome Technologies prides
itself on meeting and understanding both the clinical and technical
issues of rapidly deploying and evolving an outcomes study to fulfil
business need.
Located in London and operating globally, Outcome Technologies
systems are used by a variety of outcomes stakeholders including
pharmaceutical and medical device companies, clinician groups and
government agencies. Outcome Technologies is backed by BUPA,
a leading international health and care group caring for 7.2 million
people globally with a turnover in excess of $3billion.
The Medical Multimedia Company is a leading-edge producer of
powerful, user-friendly health economic tools for the
pharmaceutical industry.
Based in London and operating globally, our clients include 3M,
Abbott, Amgen, AstraZeneca, Aventis, Boehringer Ingelheim, Eli
Lilly, GlaxoSmithKline, Janssen-Cilag, Merck, Pfizer, Procter &
Gamble, Roche, Sanofi-Synthélabo and Wyeth.
Our latest generation of programs offers unique customization
features, allowing local adaptation within a controllable core
structure. For the first time, it is possible to combine
user-friendliness, visual impact, central control and local
flexibility – all in a single model.
The Office of Health Policy and Clinical
Outcomes, one of the few academically based outcomes research centers
nationally, has achieved a reputation of quality and excellence. As
consultants to academia and industry, we design and conduct outcomes
studies (including pharmacoeconomic studies) and performance evaluations.
Our accomplishments in the fields of migraine, diabetes, cardiology and
senior health care exemplify the depth and breadth of the expertise of the
Office staff. The Office furthers our mission of fostering quality and
cost-effective healthcare by providing our clients with a wide array of
educational programs and services. Supported by the work of our research
team, we develop and implement innovative programs for both academia and
industry. We serve as a liaison between managed care and the
pharmaceutical industry, organizing and moderating proactive and reactive
advisory boards critical to current issues or assumptions. We provide
access to decision-makers and thought leaders. We are skilled in
assessment, content, and evaluation. We are a facilitator of change,
linking our clients’ business needs with initiatives to improve
healthcare.
For more information on the Office of Health Policy and Clinical Outcomes,
please call (215) 955-6969 or visit our website: www.jefferson.edu/ohp.
We produce powerful, but extraordinarily
user-friendly, software for building and analyzing
decision trees and Markov models.
Please visit us at booth #4 for a demonstration.
If you are interested in using cost-effectiveness
models in an interactive marketing
presentation, let us show you how DATA
Interactive™ has eliminated the need to
rebuild models in Excel® or Visual Basic®.
You avoid the expense, delay and risks of
model rebuilding and you gain these benefits
without giving up any design or artistic flexibility.
The Health Economics,
Outcomes, Pricing and Market Access unit of Epinomics Research, Inc. is
now ValueMedics Research, LLC.
Our team of researchers and consultants offer a unique combination of
expertise in value determination, demonstration and communication.
Specific services include:
Strategic Consulting
Value
benchmarking and value message planning
Pricing and
contracting strategy planning
Market access
and reimbursement strategy planning
Opportunity
assessments, ROI and VOI analyses
Research and Publications
Economic
evaluations of drugs and other medical technologies
Design and
analysis of outcomes studies (economic, clinical, and
patient-reported outcomes)
Patient
compliance research and program evaluation
Pricing
research and process management
Medical need
assessments, epidemiologic research and clinico-economic
meta-analyses
Informatics and Communications Solutions
Interactive
budget impact models
Outcomes
Research Binders and training programs
Negotiations
support programs
AMCP-format
dossiers
Core Value
Dossiers for use in ex-U.S. markets
For further information, please contact
Jonothan Tierce or
Elisabeth Hazard at 703-536-2467 or
info@valuemedics.com.
